Cargando…

Comparison of two lab-scale protocols for enhanced mRNA-based CAR-T cell generation and functionality

Process development for transferring lab-scale research workflows to automated manufacturing procedures is critical for chimeric antigen receptor (CAR)-T cell therapies. Therefore, the key factor for cell viability, expansion, modification, and functionality is the optimal combination of medium and...

Descripción completa

Detalles Bibliográficos
Autores principales:	von Auw, Nadine, Serfling, Robert, Kitte, Reni, Hilger, Nadja, Zhang, Chengkang, Gebhardt, Clara, Duenkel, Anna, Franz, Paul, Koehl, Ulrike, Fricke, Stephan, Tretbar, U. Sandy
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10598065/ https://www.ncbi.nlm.nih.gov/pubmed/37875523 http://dx.doi.org/10.1038/s41598-023-45197-x

Ejemplares similares

The Epitope-Specific Anti-human CD4 Antibody MAX.16H5 and Its Role in Immune Tolerance
por: Stahl, Lilly, et al.
Publicado: (2019)

CAR T cells for treating autoimmune diseases
por: Blache, Ulrich, et al.
Publicado: (2023)

Anticancer Activity of Natural and Semi-Synthetic Drimane and Coloratane Sesquiterpenoids
por: Beckmann, Lorenz, et al.
Publicado: (2022)

CD44v6 specific CAR-NK cells for targeted immunotherapy of head and neck squamous cell carcinoma
por: Ciulean, Ioana Sonya, et al.
Publicado: (2023)

Humanized mouse model: Hematopoietic stemcell transplantation and tracking using short tandem repeat technology
por: Walcher, Lia, et al.
Publicado: (2020)

Potential solutions for manufacture of CAR T cells in cancer immunotherapy
por: Blache, Ulrich, et al.
Publicado: (2022)

Production and Application of CAR T Cells: Current and Future Role of Europe
por: Vucinic, Vladan, et al.
Publicado: (2021)

Teclistamab impairs detection of BCMA CAR-T cells
por: Glatte, Bettina, et al.
Publicado: (2023)

Taking Lessons from CAR-T Cells and Going Beyond: Tailoring Design and Signaling for CAR-NK Cells in Cancer Therapy
por: Ruppel, Katharina Eva, et al.
Publicado: (2022)

Advanced Flow Cytometry Assays for Immune Monitoring of CAR-T Cell Applications
por: Blache, Ulrich, et al.
Publicado: (2021)

Cancer Stem Cells—Origins and Biomarkers: Perspectives for Targeted Personalized Therapies
por: Walcher, Lia, et al.
Publicado: (2020)

Advantages and applications of CAR-expressing natural killer cells
por: Glienke, Wolfgang, et al.
Publicado: (2015)

Low Energy Electron Irradiation Is a Potent Alternative to Gamma Irradiation for the Inactivation of (CAR-)NK-92 Cells in ATMP Manufacturing
por: Walcher, Lia, et al.
Publicado: (2021)

Review: Sustainable Clinical Development of CAR-T Cells – Switching From Viral Transduction Towards CRISPR-Cas Gene Editing
por: Wagner, Dimitrios L., et al.
Publicado: (2022)

Foxp3(+) Regulatory T Cells in Bone and Hematopoietic Homeostasis
por: Fischer, Luise, et al.
Publicado: (2019)

Efficient Redirection of NK Cells by Genetic Modification with Chemokine Receptors CCR4 and CCR2B
por: Feigl, Frederik Fabian, et al.
Publicado: (2023)

P1415: CELLULAR DYNAMICS IN RESPONDERS AND NON-RESPONDERS AFTER THE TREATMENT OF PATIENTS WITH AGGRESSIVE B-ZELL LYMPHOMAS WITH CHIMERIC ANTIGEN RECEPTOR (CAR) T CELLS
por: Walter Georgi, Thomas, et al.
Publicado: (2023)

Diurnal difference in CAR mRNA expression
por: Kanno, Yuichiro, et al.
Publicado: (2004)

Transcriptional states of CAR-T infusion relate to neurotoxicity – lessons from high-resolution single-cell SOM expression portraying
por: Loeffler-Wirth, Henry, et al.
Publicado: (2022)

Effect of combined sublethal X-ray irradiation and cyclosporine A treatment in NOD scid gamma (NSG) mice
por: Walcher, Lia, et al.
Publicado: (2018)

Peer-assisted learning (PAL): skills lab tutors’ experiences and motivation
por: Bugaj, T. J., et al.
Publicado: (2019)

The CAR–mRNA Interaction Surface Is a Zipper Extension of the Ribosome A Site
por: Dalgarno, Carol, et al.
Publicado: (2022)

Redirected Primary Human Chimeric Antigen Receptor Natural Killer Cells As an “Off-the-Shelf Immunotherapy” for Improvement in Cancer Treatment
por: Oberschmidt, Olaf, et al.
Publicado: (2017)

Humoral Responses to Repetitive Doses of COVID-19 mRNA Vaccines in Patients with CAR-T-Cell Therapy
por: Gössi, Simona, et al.
Publicado: (2022)

How CAR T Cells Breathe
por: Forcados, Christopher, et al.
Publicado: (2022)

Characterization of the Murine Myeloid Precursor Cell Line MuMac-E8
por: Fricke, Stephan, et al.
Publicado: (2014)

Influence of nanoparticle-mediated transfection on proliferation of primary immune cells in vitro and in vivo
por: Przybylski, Susanne, et al.
Publicado: (2017)

CAR T-Cell Therapy in Hematological Malignancies
por: Haslauer, Theresa, et al.
Publicado: (2021)

Harnessing NK Cell Checkpoint-Modulating Immunotherapies
por: Chauhan, Sachin Kumar Singh, et al.
Publicado: (2020)

Allogeneic Non-Adherent Bone Marrow Cells Facilitate Hematopoietic Recovery but Do Not Lead to Allogeneic Engraftment
por: Fricke, Stephan, et al.
Publicado: (2009)

Correction: Allogeneic Non-Adherent Bone Marrow Cells Facilitate Hematopoietic Recovery but Do Not Lead to Allogeneic Engraftment
por: Fricke, Stephan, et al.
Publicado: (2015)

From lab to mass production: a policy for enabling the licensing of mRNA vaccines
por: Panagopoulos, Andreas, et al.
Publicado: (2023)

Real-World Outcome in the pre-CAR-T Era of Myeloma Patients Qualifying for CAR-T Cell Therapy
por: Brechbühl, Simon, et al.
Publicado: (2021)

Determination of CAR T cell metabolism in an optimized protocol
por: Joaquina, Sandy, et al.
Publicado: (2023)

CAR-NK Cells Targeting HER1 (EGFR) Show Efficient Anti-Tumor Activity against Head and Neck Squamous Cell Carcinoma (HNSCC)
por: Nowak, Juliette, et al.
Publicado: (2023)

Antineuronal antibodies and epilepsy: treat the patient, not the lab
por: Rüegg, Stephan
Publicado: (2021)

Cannabinoids: from pot to lab
por: Papaseit, Esther, et al.
Publicado: (2018)

Glioblastoma Molecular Classification Tool Based on mRNA Analysis: From Wet-Lab to Subtype
por: Steponaitis, Giedrius, et al.
Publicado: (2022)

Natural Killer Cell-Based Cancer Immunotherapies: From Immune Evasion to Promising Targeted Cellular Therapies
por: Hofer, Erhard, et al.
Publicado: (2017)

Underlying mechanisms of evasion from NK cells as rationale for improvement of NK cell-based immunotherapies
por: Seliger, Barbara, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_7s6o793qa1bdd25m4bmmk5gi2t